A brief description of the project, the indication or therapeutic area and roughly what stage it’s at: early R&D, approaching an MSAC, Prescribed List or PBAC submission, or dealing with a resubmission. That’s enough for us to work out the right people and come back with something specific.
Start A Conversation
Contact Us
Pulse Economics works with pharmaceutical, biotech, medtech, research and government organisations on market access, evidence, pricing and policy decisions.
Start A Strategy Discussion
Discuss your reimbursement, evidence or policy pathway
If you are considering start-up commericalisation, reimbursement and evidence strategy, modelling approach or policy submission, we welcome the opportunity to discuss how we can support you.
Request A Strategy Discussion
To help us respond efficiently, please provide a brief overview of your project, indication or policy area.
Office locations
Pulse Economics Pty Ltd
Level 1, 60 Martin Place,
Sydney NSW 2000,
29/97 Creek St,
Brisbane City QLD 4000
Contact Information
T: 02 7240 6738
Frequently Asked Questions
We have offices in Sydney (Level 1, 60 Martin Place) and Brisbane (29/97 Creek St) and work with medtech, digital health, pharmaceutical, biotech and research organisations.
Yes. We help start-ups with reimbursement readiness assessments, market scoping, indication prioritisation, early evidence planning and health economic evidence for grants and investors. Eligible medtech start-ups at TRL 5 or above can apply for a free 30-minute strategy consultation. We’re also an industry partner of ANDHealth.
It’s a strategy discussion. We use the first conversation to understand your technology, evidence and timelines well enough to say honestly whether and how we can help.

